HAVN Life Sciences Inc. HAVLF

HAVLF Company Overview

HAVN Life Sciences Inc. is a Canadian biotechnology and consumer packaged goods company focused on the research, development, and commercialization of psychedelic compounds, functional mushrooms, and natural health products. The company has operated at the intersection of the mental health, wellness, and biotechnology sectors, with an emphasis on developing standardized formulations and evidence-based products derived from psychoactive and non-psychoactive fungi. Its activities have included both scientific research initiatives and direct-to-consumer wellness product offerings.

The company’s primary revenue drivers have historically included sales of natural health and wellness products, alongside intellectual property development and research activities tied to psychedelic science. HAVN Life Sciences positioned itself as an early participant in the emerging psychedelic wellness market in North America, particularly during the expansion of investor and clinical interest in psilocybin-related therapies. Public disclosures and market filings indicate that the company evolved from a wellness-focused product platform into a broader life sciences organization seeking exposure to mental health therapeutics and nutraceutical innovation.